Stay updated on Tepotinib & Gefitinib in NSCLC Clinical Trial

Sign up to get notified when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tepotinib & Gefitinib in NSCLC Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    10 days ago
    Change Detected
    Summary
    An administrative revision tag 'Revision: v3.3.3' was added and the 'HHS Vulnerability Disclosure' link along with the previous 'Revision: v3.3.2' were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-17T18:55:11.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Publications section updated to clarify that publications are provided voluntarily by the person entering study information. The revision tag is updated to v3.3.2, replacing the old v3.2.0 wording.
    Difference
    0.1%
    Check dated 2025-11-26T13:47:46.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page no longer shows the site-wide government funding status notice. The study details and data presented on the page remain unchanged.
    Difference
    0.2%
    Check dated 2025-11-19T09:24:41.000Z thumbnail image
  6. Check
    60 days ago
    Change Detected
    Summary
    The page content appears unchanged with no additions or deletions impacting core information, pricing, or availability.
    Difference
    0.2%
    Check dated 2025-10-28T17:54:59.000Z thumbnail image
  7. Check
    83 days ago
    Change Detected
    Summary
    Upgrade to v3.2.0 with a government operating-status notice and links; replaces v3.1.0.
    Difference
    1%
    Check dated 2025-10-06T08:18:36.000Z thumbnail image
  8. Check
    90 days ago
    Change Detected
    Summary
    Version updated from v3.0.2 to v3.1.0, indicating a newer release.
    Difference
    0.0%
    Check dated 2025-09-29T04:50:41.000Z thumbnail image

Stay in the know with updates to Tepotinib & Gefitinib in NSCLC Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tepotinib & Gefitinib in NSCLC Clinical Trial page.